ArticleHepatology communications2018

Telomerase reverse transcriptase mutations in plasma DNA in patients with hepatocellular carcinoma or cirrhosis: Prevalence and risk factors.

Jingjing Jiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.